Investing.com - Smith&Nephew SNATS reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Smith&Nephew SNATS announced earnings per share of $0.2 on revenue of $1.29B. Analysts polled by Investing.com anticipated EPS of $0.8 on revenue of $1.32B.
Smith&Nephew SNATS shares are down 23.57% from the beginning of the year, still down 35.95% from its 52 week high of $41.31 set on July 29, 2021. They are under-performing the EUR/USD which is down 0% from the start of the year.
Smith&Nephew SNATS follows other major Healthcare sector earnings this month
Smith&Nephew SNATS's report follows an earnings beat by UnitedHealth on July 15, who reported EPS of $5.57 on revenue of $80.33B, compared to forecasts EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on July 19 with second quarter EPS of $2.59 on revenue of $24.02B, compared to forecast for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar